Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
Clinical trial NCT01479465 · TERMINATED
Trial details
- NCT number
- NCT01479465
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.